Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation
Autor: | Beers, Stephen A., Chan, Claude H.T., James, Sonya, French, Ruth R., Attfield, Kathrine E., Brennan, Claire M., Ahuja, Anupama, Shlomchik, Mark J., Cragg, Mark S. *, Glennie, Martin J. |
---|---|
Zdroj: | In Blood 15 November 2008 112(10):4170-4177 |
Databáze: | ScienceDirect |
Externí odkaz: |